164 related articles for article (PubMed ID: 33917330)
1. Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer.
Opławski M; Nowakowski R; Średnicka A; Ochnik D; Grabarek BO; Boroń D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917330
[TBL] [Abstract][Full Text] [Related]
2. Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines In Vitro Study.
Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
[TBL] [Abstract][Full Text] [Related]
3. Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer.
Czerwiński M; Bednarska-Czerwińska A; Ordon P; Gradzik M; Oplawski M; Boroń D; Zientek H; Ogloszka O; Grabarek BO
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829764
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Differences in the Expression of mRNAs and miRNAs Associated with Drug Resistance in Endometrial Cancer Cells Treated with Salinomycin.
Januszyk P; Januszyk K; Wierzbik-Strońska M; Boroń D; Grabarek B
Curr Pharm Biotechnol; 2021; 22(4):541-548. PubMed ID: 32598254
[TBL] [Abstract][Full Text] [Related]
5. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
[TBL] [Abstract][Full Text] [Related]
6. [Expression of melatonin receptors genes and genes associated with regulation of their activity in endometrial cancer].
Witek A; Jęda A; Baliś M; Orchel J; Sikora B; Skubis A; Szota-Czyż J; Janikowski T; Mazurek U
Ginekol Pol; 2015 Apr; 86(4):248-55. PubMed ID: 26117982
[TBL] [Abstract][Full Text] [Related]
7. [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].
Jeda A; Witek A; Janikowska G; Cwynar G; Janikowski T; Ciałon M; Orchel J; Mazurek U
Ginekol Pol; 2014 Mar; 85(3):172-9. PubMed ID: 24783427
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Tomala B; Leśniak E; Adwent I; Januszyk P; Dąbruś D; Boroń D
Curr Pharm Biotechnol; 2019; 20(6):483-488. PubMed ID: 30961491
[TBL] [Abstract][Full Text] [Related]
9. Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Januszyk P; Adwent I; Dąbruś D; Leśniak E; Kiełbasiński R; Kieszkowski P; Boroń D
Med Sci Monit; 2019 Jun; 25():4569-4574. PubMed ID: 31217417
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
[TBL] [Abstract][Full Text] [Related]
11. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J
J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer.
Cicchillitti L; Corrado G; Carosi M; Dabrowska ME; Loria R; Falcioni R; Cutillo G; Piaggio G; Vizza E
Oncotarget; 2017 Jan; 8(5):7935-7945. PubMed ID: 27974701
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer.
Talkowski K; Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(2):317-326. PubMed ID: 32564748
[TBL] [Abstract][Full Text] [Related]
16. Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.
Opławski M; Michalski M; Witek A; Michalski B; Zmarzły N; Jęda-Golonka A; Styblińska M; Gola J; Kasprzyk-Żyszczyńska M; Mazurek U; Plewka A
Mol Med Rep; 2017 Sep; 16(3):2547-2555. PubMed ID: 28656251
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Kieszkowski P; Januszyk P; Kiełbasiński K; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2020; 21(1):45-51. PubMed ID: 31544715
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a inhibits epithelial-mesenchymal transition of lens epithelial cells by targeting Notch1.
Han R; Hao P; Wang L; Li J; Shui S; Wang Y; Ying M; Liu J; Tang X; Li X
Exp Eye Res; 2019 Aug; 185():107684. PubMed ID: 31158382
[TBL] [Abstract][Full Text] [Related]
19. Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line.
Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Wierzbik-Strońska M; Oplawski M
Curr Pharm Biotechnol; 2020; 21(12):1269-1277. PubMed ID: 32400328
[TBL] [Abstract][Full Text] [Related]
20. Mammaglobin B expression in human endometrial cancer.
Tassi RA; Bignotti E; Falchetti M; Calza S; Ravaggi A; Rossi E; Martinelli F; Bandiera E; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2008; 18(5):1090-6. PubMed ID: 18021217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
